Cargando…
The Role of DBR1 as a Candidate Prognosis Biomarker in Esophageal Squamous Cell Carcinoma
Aims: Esophageal squamous cell carcinoma (ESCC) is one of the most prevalent malignancies with unfavorable clinical outcomes and limited therapeutic methods. As a key enzyme in RNA metabolism, debranching RNA Lariats 1 (DBR1) is involved in intron turnover and biogenesis of noncoding RNA. Although c...
Autores principales: | Xu, Xiaoqin, Yang, Xin, Liu, Xue, Bi, Yanghui, Kong, Pengzhou, Wang, Yanqiang, Cheng, Xiaolong, Xi, Yanfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902023/ https://www.ncbi.nlm.nih.gov/pubmed/35244467 http://dx.doi.org/10.1177/15330338221083105 |
Ejemplares similares
-
Integrative Genomic Analyses of 1,145 Patient Samples Reveal New Biomarkers in Esophageal Squamous Cell Carcinoma
por: Zou, Binbin, et al.
Publicado: (2022) -
EP300 as an oncogene correlates with poor prognosis in esophageal squamous carcinoma
por: Bi, Yanghui, et al.
Publicado: (2019) -
CDCA7 Facilitates Tumor Progression by Directly Regulating CCNA2 Expression in Esophageal Squamous Cell Carcinoma
por: Li, Hongyi, et al.
Publicado: (2021) -
MYH9 promotes cell metastasis via inducing Angiogenesis and Epithelial Mesenchymal Transition in Esophageal Squamous Cell Carcinoma
por: Yang, Bin, et al.
Publicado: (2020) -
Elevated FAM84B promotes cell proliferation via interacting with NPM1 in esophageal squamous cell carcinoma
por: Wang, Fang, et al.
Publicado: (2022)